Skip to main content

Table 3 The gene expression according to clinicopathological characteristics

From: Long non-coding RNA AC087388.1 as a novel biomarker in colorectal cancer

 

SLC16A1-AS1

P-value

AC087388.1

P-value

ELFN1-AS1

P-value

Mean

Std. Error

Mean

Std. Error

Mean

Std. Error

Sex

 Male

0.89

0.32

0.14

2.33

0.20

0.97

4.29

0.31

0.22

 Female

1.39

0.32

 

2.51

0.32

 

5.23

0.24

 

Age (y)

 58 < 

0.97

0.34

0.37

2.82

0.24

0.02

4.59

0.30

0.94

  ≤ 58

1.25

0.32

 

1.98

0.25

 

4.82

0.30

 

Tumor size (cm)

 4.5 > 

0.97

0.34

0.36

2.63

0.30

0.63

4.59

0.33

0.95

  ≤ 4.5

1.23

0.32

 

2.22

0.21

 

4.80

0.27

 

TNM

 I

0.62

0.69

0.25

2.87

0.65

0.87

4.36

0.61

0.88

 II

1.78

0.56

 

1.92

0.34

 

5.26

0.54

 

 III

0.94

0.25

 

2.50

0.21

 

4.55

0.23

 

Grade

 I

1.21

0.46

0.79

2.28

0.32

0.68

4.56

0.39

0.51

 II

1.11

0.33

 

2.34

0.23

 

5.26

0.27

 

 III

0.85

0.28

 

2.96

0.50

 

3.36

0.49

 

KRAS mutation

 positive

1.17

0.33

0.25

2.60

0.22

0.56

5.26

0.28

0.57

 Negative

1.05

0.34

 

2.25

0.30

 

4.22

0.32

 

BRAF mutation

 positive

0.46

0.24

0.01

2.35

0.21

0.96

4.06

0.25

0.69

 Negative

1.3

0.47

 

2.43

0.36

 

4.90

0.35

 

NRAS mutaion

 positive

 

0.24

0.97

 

0.18

0.36

 

0.21

0.46

 Negative

1.11

  

2.39

  

4.77

 Â